{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:36:01Z","timestamp":1791549361841,"version":"4.3.4"},"reference-count":39,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2018,12,6]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Arboviruses have been spreading rapidly throughout the Western Hemisphere in recent decades.\nAmong the arboviruses with high morbidity and mortality are the members of the Alphavirus and\nFlavivirus genera. Within the first genus, Chikungunya Virus (CHIKV) is considered one of the most\nchallenging human arboviral infection worldwide, against which there is no specific antivirals. Flaviviruses\nare some of the main viruses responsible for encephalitis, haemorrhagic disease and developmental\ndefects. Dengue virus (DENV), Japanese Encephalitis Virus (JEV), West Nile Virus (WNV) and\nZika Virus (ZIKV) are examples of flaviviruses without clinically approved antiviral agents. Thus, the\nsearch for new antivirals becomes highly important. One of the strategies that can be employed to obtain\nnew drugs is the identification and utilization of privileged structures. Isatin is an example of a\nprivileged molecular framework, displaying a broad spectrum of biological activities, including antiviral\naction. Obtaining and studying the antiviral properties of isatin derivatives have helped to identify\nimportant agents with potential activity against different arboviruses. This article reviews some of\nthese isatin derivatives, their structures and antiviral properties reported against this important group of\nviruses.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557518666180424093305","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T12:02:47Z","timestamp":1524657767000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Isatin Derivatives and Their Antiviral Properties Against Arboviruses: A Review"],"prefix":"10.2174","volume":"19","author":[{"given":"Paulo Andr\u00e9 Teixeira","family":"De Moraes Gomes","sequence":"first","affiliation":[{"name":"Medicinal Chemistry Planning Laboratory, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife-PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindomar J.","family":"Pena","sequence":"additional","affiliation":[{"name":"Department of Virology and of Experimental Therapeutics, Aggeu Magalh\u00e3es Institute, Oswaldo Cruz Foundation (Fiocruz), Recife-PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C. Lima","family":"Leite","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Planning Laboratory, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife-PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1600297","author":"Fauci A.S.","year":"2016","unstructured":"Fauci AS, Morens DM. N Engl J Med, Zika Virus in the Americas\u2014Yet Another Arbovirus Threat.,, 2016, ,, -,10.1056\/NEJMp1600297","journal-title":"N Engl J Med"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2017.03.006","volume":"58","author":"Wahid B.","year":"2017","unstructured":"Wahid B, Ali A, Rafique S, Idrees M. Int J Infect Dis, Global expansion of chikungunya virus: mapping the 64-year history.,, 2017, 58,, 69-76,","journal-title":"Int J Infect Dis"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jmgm.2013.07.001","volume":"44","author":"Rashad A.A.","year":"2013","unstructured":"Rashad AA, Keller PA. J Mol Graph Model, Structure based design towards the identification of novel binding sites and inhibitors for the Chikungunya virus envelope proteins.,, 2013, 44,, 241-252,","journal-title":"J Mol Graph Model"},{"key":"ref=4","first-page":"59","volume":"1","author":"Jadav S.S.","year":"2014","unstructured":"Jadav SS, Korupolu P, Sinha BN, Jayaprakash V. J Pharmaceut Chem, Chikungunya epidemiological survey and Current available inhibitors.,, 2014, 1,, 59-67,","journal-title":"J Pharmaceut Chem"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.50.4.1320-1329.2006","volume":"50","author":"Puig-Basagoiti F.","year":"2006","unstructured":"Puig-Basagoiti F, Tilgner M, Forshey BM, Philpott SM, Espina NG, Wentworth DE, Goebel SJ, Masters PS, Falgout B, Ren P, Ferguson DM. Antimicrob Agents Chemother, Triaryl pyrazoline compound inhibits flavivirus RNA replication.,, 2006, 50,, 1320-1329,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijid.2016.02.086","volume":"45","author":"Solomon T.","year":"2016","unstructured":"Solomon T. Int J Infect Dis, Flavivirus encephalitis and other neurological syndromes (Japanese encephalitis, WNV, Tick borne encephalits, Dengue, Zika virus).,, 2016, 45,, 24-,","journal-title":"Int J Infect Dis"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s13365-014-0285-z","volume":"20","author":"Daep C.A.","year":"","unstructured":"Daep CA, Mu\u00f1oz-Jord\u00e1n JL, Eugenin EA. J Neurovirol, Flaviviruses, an expanding threat in public health: Focus on dengue, West Nile, and Japanese encephalitis virus.,, , 20,, 539-560,","journal-title":"J Neurovirol"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1021\/jm800412d","volume":"51","author":"Li Z.","year":"2008","unstructured":"Li Z, Khaliq M, Zhou Z, Post CB, Kuhn RJ, Cushman M. J Med Chem, Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins.,, 2008, 51,, 4660-4671,","journal-title":"J Med Chem"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/JVI.01840-06","volume":"81","author":"Bai F.","year":"2007","unstructured":"Bai F, Town T, Pradhan D, Cox J, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E. J Virol, Antiviral peptides targeting the west nile virus envelope protein.,, 2007, 81,, 2047-2055,","journal-title":"J Virol"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/092986706775197999","volume":"13","author":"Costantino L.","year":"2006","unstructured":"Costantino L, Barlocco D. Curr Med Chem, Privileged structures as leads in medicinal chemistry.,, 2006, 13,, 65-85,","journal-title":"Curr Med Chem"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mrgentox.2010.11.006","volume":"719","author":"C\u00e2ndido-Bacani P.M.","year":"2011","unstructured":"C\u00e2ndido-Bacani PM, dos Reis MB, Serpeloni JM, Calvo TR, Vilegas W, Varanda EA, C\u00f3lus IM. Mutat Res Genet Toxicol Environ Mutagen, Mutagenicity and genotoxicity of isatin in mammalian cells in vivo.,, 2011, 719,, 47-51,","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"ref=12","first-page":"177","volume":"57","author":"Ren A.","year":"2015","unstructured":"Ren A, Wang Q, Fang Z, Gao M, Wang H, Zhang J, Xu W, Yue W, Yin L, Liu Z, Li X, Ding B. Panminerva Med, Pharmacokinetic study of isatin in dog plasma by liquid chromatography tandem mass spectrometry.,, 2015, 57,, 177-182,","journal-title":"Panminerva Med"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.3892\/etm.2016.3232","volume":"11","author":"Ren A.","year":"2016","unstructured":"Ren A, Su B, Ye S, Wei X, Fang Z, Wang Q, Zhang J, Xu W, Yue W, Yin L, Liu Z, Li X, Ding B. Exp Ther Med, A pharmacokinetic study of Isatin in Beagles\u2019 bodies.,, 2016, 11,, 2225-2228,","journal-title":"Exp Ther Med"},{"key":"ref=14","first-page":"397-414","volume":"9","author":"Vine K.L.","year":"2009","unstructured":"Vine KL, Matesic L, Locke JM, Ranson M, Skropeta D. Anti-Cancer Agents Med.\nChem. (Formerly Curr. Med. Chem.-Anti-Cancer Agents),, Cytotoxic and anticancer activities of isatin and its derivatives: A\ncomprehensive review from 2000-2008., , 2009","journal-title":"Anti-Cancer Agents Med\nChem (Formerly Curr Med Chem-Anti-Cancer Agents),"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bmc.2015.12.008","volume":"24","author":"Cihan-\u00dcst\u00fcnda\u011f G.","year":"2016","unstructured":"Cihan-\u00dcst\u00fcnda\u011f G, G\u00fcrsoy E, Naesens L, Ulusoy-G\u00fczeldemirci N, \u00c7apan G. Bioorg Med Chem, Synthesis and antiviral properties of novel indole-based thiosemicarbazides and 4-thiazolidinones.,, 2016, 24,, 240-246,","journal-title":"Bioorg Med Chem"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/ejoc.201600143","author":"Laursen S.R.","year":"2016","unstructured":"Laursen SR, Jensen MT, Lindhardt AT, Jacobsen MF, Skrydstrup T. Eur J Org Chem, A Palladium-Catalyzed Double Carbonylation Approach to Isatins from 2-Iodoanilines.,, 2016, 24,, 1881-1885,","journal-title":"Eur J Org Chem"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.1965.tb12545.x","volume":"130","author":"Bauer D.J.","year":"1965","unstructured":"Bauer DJ. Ann N Y Acad Sci, Clinical experience with the antiviral drug Marboran\u00ae (1-methylisatin 3-thiosemicarbazone).,, 1965, 130,, 110-117,","journal-title":"Ann N Y Acad Sci"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0166-3542(85)90029-4","volume":"5","author":"Ronen D.","year":"1985","unstructured":"Ronen D, Nir E, Teitz Y. Antiviral Res, Effect of N-methylisatin-\u03b2-4\u2032: 4\u2032-diethylthiosemicarbazone on intracellular Moloney leukemia virus constituents.,, 1985, 5,, 249-254,","journal-title":"Antiviral Res"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0166-3542(94)90077-9","volume":"24","author":"Teitz Y.A.","year":"1994","unstructured":"Teitz YA, Ronen D, Vansover A, Stematsky T, Riggs JL. Antiviral Res, Inhibition of human immunodeficiency virus by N-methylisatin-\u03b24\u2032: 4\u2032-diethylthiosemicarbazone and N-allylisatin-\u03b2-4\u2032: 4\u2032-diallythiosemicarbazone.,, 1994, 24,, 305-314,","journal-title":"Antiviral Res"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.bmcl.2011.02.037","volume":"21","author":"Kang I.J.","year":"2011","unstructured":"Kang IJ, Wang LW, Hsu TA, Yueh A, Lee CC, Lee YC, Lee CY, Chao YS, Shih SR, Chern JH. Bioorg Med Chem Lett, Isatin-\u03b2-thiosemicarbazones as potent herpes simplex virus inhibitors.,, 2011, 21,, 1948-1952,","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1021\/cb400775z","volume":"9","author":"Zhang H.M.","year":"2014","unstructured":"Zhang HM, Dai H, Hanson PJ, Li H, Guo H, Ye X, Hemida MG, Wang L, Tong Y, Qiu Y, Liu S. ACS Chem Biol, Antiviral activity of an isatin derivative via induction of PERK-Nrf2-mediated suppression of cap-independent translation.,, 2014, 9,, 1015-1024,","journal-title":"ACS Chem Biol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1126\/science.154.3750.796","volume":"154","author":"Bauer D.J.","year":"1966","unstructured":"Bauer DJ, Apostolov K. Science, Adenovirus multiplication: Inhibition by methisazone.,, 1966, 154,, 796-797,","journal-title":"Science"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1749-6632.1970.tb53421.x","volume":"173","author":"Bauer D.J.","year":"1970","unstructured":"Bauer DJ, Apostolov K, Selway JW. Ann N Y Acad Sci, Activity of Methisazone against Viruses.,, 1970, 173,, 314-319,","journal-title":"Ann N Y Acad Sci"},{"key":"ref=24","first-page":"314","volume":"305","author":"Teitz Y.","year":"1994","unstructured":"Teitz Y, Ronen D, Vasover A, Stematsky T, Riggs JL. Antiviral Res, Inhibition of human immunodeficiency virus by N-methylisatin-\u03b24\u2032:4\u2032-diethylthiosemicarbazone and N-allylisatin-\u03b2-4\u2032:4\u2032-diallythiosemi-carbazone.,, 1994, 305,, 314-,","journal-title":"Antiviral Res"},{"key":"ref=25","volume":"6","author":"Mishra P.","year":"2016","unstructured":"Mishra P, Kumar A, Mamidi P, Kumar S, Basantray I, Saswat T, Das I, Nayak TK, Chattopadhyay S, Subudhi BB, Chattopadhyay S. Scientif. Reports, Inhibition of chikungunya virus replication by 1-\n[(2-methylbenzimidazol-1-yl) methyl]-2-oxo-indolin-3-ylidene]\namino] thiourea (mbzm-n-ibt)., , 2016","journal-title":"Scientif Reports"},{"key":"ref=26","first-page":"Ed(1)","author":"Rodrigues Faria N.","year":"2016","unstructured":"Rodrigues Faria N, Louren\u00e7o J, Marques de Cerqueira E, Maia de Lima M, Pybus O, Carlos Junior Alcantara L. PLOS Curr.\nOutbreaks,, Epidemiology\nof chikungunya virus in bahia, Brazil, 2014-2015., , 2016","journal-title":"PLOS Curr\nOutbreaks,"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1743-422X-5-64","volume":"5","author":"Sebastian L.","year":"2008","unstructured":"Sebastian L, Desai A, Shampur MN, Perumal Y, Sriram D, Vasanthapuram R. Virol J, N-methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo.,, 2008, 5,, 64-,","journal-title":"Virol J"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1472-765X.2012.03282.x","volume":"55","author":"Sebastian L.","year":"2012","unstructured":"Sebastian L, Desai A, Yogeeswari P, Sriram D, Madhusudana SN, Ravi V. Lett Appl Microbiol, Combination of N-methylisatin-\u03b2-thiosemicarbazone derivative (SCH16) with ribavirin and mycophenolic acid potentiates the antiviral activity of SCH16 against Japanese encephalitis virus in vitro.,, 2012, 55,, 234-239,","journal-title":"Lett Appl Microbiol"},{"key":"ref=29","author":"Minami M.","unstructured":"Minami M, Hamaue N, Hirafuji M, Saito H, Hiroshige T, Ogata A, Tashiro K, Parvez SH, , ,Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson\u2019s disease induced by the Japanese encephalitis virus., , 2006 (pp. 87-95). Springer Vienna., In Oxidative Stress and Neuroprotection., ,-","journal-title":"In Oxidative Stress and Neuroprotection"},{"key":"ref=30","first-page":"7","author":"Bl\u00e1zquez A.B.","year":"2016","unstructured":"Bl\u00e1zquez AB, Mart\u00edn-Acebes MA, Saiz JC. Front Microbiol, Inhibition of west nile virus multiplication in cell culture by Anti-Parkinsonian drugs.,, 2016, 55,, 7-,","journal-title":"Front Microbiol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1089\/vim.2005.18.474","volume":"18","author":"Gilbert C.","year":"2005","unstructured":"Gilbert C, Bergeron M, M\u00e9thot S, Gigu\u00e8re JF, Tremblay MJ. Viral Immunol, Statins could be used to control replication of some viruses, including HIV-1.,, 2005, 18,, 474-489,","journal-title":"Viral Immunol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.virol.2008.06.045","volume":"380","author":"Asenjo A.","year":"2008","unstructured":"Asenjo A, Gonz\u00e1lez-Armas JC, Villanueva N. Virology, Phosphorylation of human respiratory syncytial virus P protein at serine 54 regulates viral uncoating.,, 2008, 380,, 26-33,","journal-title":"Virology"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.01717-10","volume":"85","author":"V\u00e1zquez-Calvo \u00c1.","year":"2011","unstructured":"V\u00e1zquez-Calvo \u00c1, Saiz JC, Sobrino F, Mart\u00edn-Acebes MA. J Virol, Inhibition of enveloped virus infection of cultured cells by valproic acid.,, 2011, 85,, 1267-1274,","journal-title":"J Virol"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1073\/pnas.0912966107","volume":"107","author":"Gastaminza P.","year":"2010","unstructured":"Gastaminza P, Whitten-Bauer C, Chisari FV. Proc Natl Acad Sci, Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection.,, 2010, 107,, 291-296,","journal-title":"Proc Natl Acad Sci"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/ml500521r","volume":"6","author":"Zou B.","year":"2015","unstructured":"Zou B, Chan WL, Ding M, Leong SY, Nilar S, Seah PG, Liu W, Karuna R, Blasco F, Yip A, Chao A. ACS Med Chem Lett, Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors.,, 2015, 6,, 344-348,","journal-title":"ACS Med Chem Lett"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/jmv.24655","volume":"89","author":"Padmanabhan P.","year":"2017","unstructured":"Padmanabhan P, Khaleefathullah S, Kaveri K, Palani G, Ramanathan G, Thennarasu S, Tirichurapalli Sivagnanam U. J Med Virol, Antiviral activity of Thiosemicarbazones derived from \u03b1-amino acids against Dengue virus.,, 2017, 89,, 546-552,","journal-title":"J Med Virol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2009.02.204","volume":"83","author":"Zhang X.G.","year":"2009","unstructured":"Zhang XG, Mason PW, Dubovi EJ, Xu X, Bourne N, Renshaw RW, Block TM, Birk AV. Antiviral Res, Antiviral activity of geneticin against dengue virus.,, 2009, 83,, 21-27,","journal-title":"Antiviral Res"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1021\/jm100593s","volume":"53","author":"Wu R.","year":"2010","unstructured":"Wu R, Smidansky ED, Oh HS, Takhampunya R, Padmanabhan R, Cameron CE, Peterson BR. J Med Chem, Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses.,, 2010, 53,, 7958-7966,","journal-title":"J Med Chem"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"e112351","DOI":"10.1371\/journal.pone.0112351","volume":"9","author":"Muller V.D.","year":"2014","unstructured":"Muller VD, Soares RO, dos Santos-Junior NN, Trabuco AC, Cintra AC, Figueiredo LT, Caliri A, Sampaio SV, Aquino VH. PLoS One, Phospholipase A 2 Isolated from the Venom of crotalus durissus terrificus inactivates dengue virus and other enveloped viruses by disrupting the viral envelope.,, 2014, 9,, e112351-,","journal-title":"PLoS One"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/161528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T14:07:54Z","timestamp":1562854074000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/161528\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557518666180424093305","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-08-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}